Clinical outcomes and bleeding events associated with tirofiban combined with intravenous alteplase in acute ischaemic stroke: a retrospective single-center study

作者
Huifang Pang,Hailong Sui,Chunli Fu
出处
期刊:Frontiers in Neurology [Frontiers Media]
卷期号:17: 1858221-1858221
标识
DOI:10.3389/fneur.2026.1858221
摘要

Objective To evaluate the clinical efficacy and bleeding risk of tirofiban combined with intravenous alteplase in patients with acute ischaemic stroke (AIS). Methods This retrospective study identified 90 AIS patients who were divided according to the treatment received into a combined group (CG, n = 45; tirofiban plus alteplase) and an alteplase group (AG, n = 45; alteplase alone). The 90-day modified Rankin Scale outcome was defined as the primary outcome, whereas neurological deficits, coagulation parameters, inflammatory biomarkers, post-treatment vascular status, activities of daily living, and bleeding events were evaluated as secondary or exploratory outcomes. Results Baseline characteristics were comparable between the two groups ( p > 0.05). NIHSS scores in the CG were significantly lower than in the AG at 24 h, 7 days, and 14 days after treatment (all p < 0.01). Post-treatment PT, APTT, and D-dimer were higher in the CG, while fibrinogen was lower (all p < 0.001). At day 7, hs-CRP, IL-6, and TNF- α were significantly lower in the CG (all p < 0.001). The CG had a higher rate of favorable post-treatment vascular status ( χ 2 = 4.731, p = 0.030), a higher proportion of favorable 90-day outcomes defined as mRS ≤ 2 ( χ 2 = 5.414, p = 0.020), and higher Barthel Index scores at day 14 ( p < 0.001). The total bleeding rate was 28.89% in the CG and 17.78% in the AG, with no statistically significant between-group difference ( χ 2 = 1.543, p = 0.214). Conclusion In this retrospective single-center cohort, tirofiban combined with alteplase was associated with lower NIHSS scores, better post-treatment vascular status, and higher rates of favorable 90-day outcomes, suggesting that combination therapy may potentially improve neurological recovery, attenuate inflammation, and optimize post-treatment vascular status in patients with AIS; however, these findings require confirmation in larger randomized trials.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LL完成签到,获得积分10
刚刚
刚刚
刚刚
刚刚
刚刚
1秒前
2秒前
舒服的忆南完成签到,获得积分10
2秒前
竞鹤完成签到,获得积分10
2秒前
科目三的应助被QFJ采纳,获得20
2秒前
2秒前
lingling发布了新的文献求助10
3秒前
ST发布了新的文献求助10
3秒前
lexin完成签到,获得积分20
3秒前
皇后发布了新的文献求助10
3秒前
bae发布了新的文献求助30
4秒前
4秒前
lucy发布了新的文献求助10
4秒前
XLL完成签到,获得积分10
4秒前
Akim的应助被谨慎的秋烟采纳,获得10
4秒前
川川子完成签到,获得积分10
5秒前
5秒前
诱阙寰发布了新的文献求助10
5秒前
王俊完成签到,获得积分10
5秒前
无极微光的应助被芝士小熊采纳,获得20
5秒前
5秒前
娜娜发布了新的文献求助10
5秒前
6秒前
6秒前
SJ发布了新的文献求助10
6秒前
楚牧发布了新的文献求助10
6秒前
6秒前
7秒前
8秒前
zrf完成签到,获得积分10
8秒前
千倾完成签到,获得积分10
9秒前
hujun发布了新的文献求助10
9秒前
认真听露发布了新的文献求助10
9秒前
lucky发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8155737
求助须知:如何正确求助?哪些是违规求助? 9552018
关于积分的说明 21707687
捐赠科研通 7744923
什么是DOI,文献DOI怎么找? 3426177
关于科研通互助平台的介绍 2551229
邀请新用户注册赠送积分活动 2469949